Cite Filings / OTLK
Feed Companies Filings Check
Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Filings Insiders Search text
All 833 Financials 225 Shareholder Meetings 22 Executive Compensation 206 Insider Trading 305 Beneficial Ownership Interest 80 Business Combinations 177 Public Offerings 128 Mutual Funds and ETFs 13 Others 86
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-06-01
  3. DEF 14A Proxy Proxy Statement 2026-01-26
  4. DEF 14A Proxy Proxy Statement 2025-02-10
  5. DEF 14A Proxy Proxy Statement 2024-06-26
  6. DEF 14A Proxy Proxy Statement 2024-02-08
  7. DEF 14A Proxy Proxy Statement 2023-02-15
  8. DEF 14A Proxy Proxy Statement 2022-01-27
  9. DEF 14A Proxy Proxy Statement 2021-02-22
  10. DEF 14A Proxy Proxy Statement 2020-08-18
  11. DEF 14A Proxy Proxy Statement 2020-02-14
  12. DEF 14A Proxy Proxy Statement 2019-08-01
  13. DEF 14A Proxy Proxy Statement 2018-08-17
  14. DEF 14A Proxy Proxy Statement 2017-09-29

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…